[On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
D000368:Aged; D001933:Brain Stem / Q000187:drug effects; D002090:Butyrophenones / Q000009:adverse effects; D002490:Central Nervous System / Q000187:drug effects*; D014695:Cerebral Ventriculography; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D010546:Perphenazine / Q000009:adverse effects; D010551:Personality; D014149:Tranquilizing Agents / Q000009:adverse effects*
D002090:Butyrophenones; D014149:Tranquilizing Agents; D010546:Perphenazine; D005476:Fluphenazine
Zur Wirkungsweise und zur Frage zentralorganischer Spätschäden der neuroleptischen Dauerbehandlung.